To present an investigation into the intake of cannabinoids in a population of adolescents and young adults with cancer.
Methods:
Sixty-six patients took part in the research: 27 reported having used cannabinoids, 21 before diagnosis; among the latter, 10 increased use during treatment.
Results:
Benefits were reported by 19% of responders regarding anxiety control, 24% for nausea, 29% for pain control and improvement of sleep, and 48% for appetite improvement.
Conclusions:
Cannabis use by patients may often be unknown to caregivers. Studying this subject may help to better define important therapeutic aspects of these substances.
JohnsonJRBurnell-NugentMLossignolD, et al. Double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage2010; 39: 167–179.
2.
WareMAWangTShapiroS, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ2010; 182: E694–E701.
3.
JatoiAWindschitlHELoprinziCL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group Study. J Clin Oncol2002; 20: 567–573.
4.
TodaroB. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. J Natl Comprehens Cancer Netw2012; 10: 487–492.
5.
AbramsDI. Using medical cannabis in an oncology practice. Oncology2016; 30: 597–404.
6.
BirdsallSMBirdsallTTimsLA. The use of medical marijuana in cancer. Curr Oncol Rep2016; 18: 40.
7.
WhitingPFWolffRFDeshpandeS, et al. Cannabinoids for medical use: a systematic review and meta-analyses. JAMA2015; 313: 2456–2473.
8.
AnanthPReed-WestonAWolfeJ. Medical marijuana in pediatric oncology: a review of the evidence and implications for practice. Pediatr Blood Cancer2018; 65.
9.
BertrandABoyleHMoreauxJ. Does consumption of tobacco, alcohol, and cannabis in adolescents and young adults with cancer affect the use of analgesics during hospitalizations?Arch Pediatr2016; 23: 353–359.
10.
SchleiderLBMechoulamRLedermanV, et al. Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med2018; 1: 37–43.
11.
National Academies of Sciences, Engineering and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: National Academies Press; 2017.
12.
CathcartPde GiorgioAStebbingJ. Cannabis and cancer: reality or pipe dream?Lancet Oncol2015; 16: 1291–1292.
13.
LevineAClemenzaKRynnM, et al. evidence for the risks and consequences of adolescent cannabis exposure. J Am Acad Child Adolesc Psychiatry2017; 56: 214–225.
14.
CridgeBJRosengrenRJ. Critical appraisal of the potential use of cannabinoids in cancer management. Cancer Manag Res2013; 5: 301–313.
15.
MolinaroSBenedettiEScaleseM, et al. Prevalence of youth gambling and potential influence of substance use and other risk factors throughout 33 European countries: first results from the 2015 ESPAD study. Addiction2018; 113: 1862–1873.
16.
ReithmeierDTang-WaiRSeifertB, et al. The protocol for the Cannabidiol in Children with Refractory Epileptic Encephalopathy (CARE-E) study: a phase 1 dosage escalation study. BMC Pediatr2018; 18: 221.
17.
FriedmanDFrenchJAMaccarroneM. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. Lancet Neurol2019; 18: 504–512.
18.
AbramsDI. Should oncologists recommend cannabis?Curr Treat Options Oncol2019; 20: 59.
19.
DonovanKAOberoi-JassalRChangYD, et al. Cannabis use in young adult cancer patients. J Adolesc Young Adult Oncol. 2020; 9: 30–35.
